Nebraska Faces Losses to Drug Development, Jobs and Patient Health According to New Study
A new study estimates that proposed Federal Government-mandated drug pricing policies will amount to 237 fewer FDA approvals and up to 4,000 lost jobs for Nebraska workers over the next 10 years. Read more